Physician

Michael K Weil, M.D.

According to 2025 Medicare claims, Michael Weil, M.D. (NPI: 1780750802) practices dermatology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is MICHAEL K WEIL, MD, APMC (NPI: 1730255878; TIN: 72-1481637) and primary practice location at 70461-1125.

Weil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 432 traditional Medicare patients, billed 5,224 HCPCS/CPT codes, and received $345,302 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,616 prescription claims across 421 beneficiaries totaling $1,062,487 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 59 records totaling $1,112. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $171,089 to $345,302. Similarly, Part D prescription costs have risen steadily, from $198,935 to $1,062,487. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$224K$448K2015 Medicare payment: $171,089 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $197,899 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $204,928 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $179,524 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $178,310 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $162,209 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $131,878 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $252,386 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $448,463 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $345,302 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156174,260$171,089
20166204,666$197,899
20176154,418$204,928
20186594,725$179,524
20196554,932$178,310
20205383,816$162,209
20214793,397$131,878
20224724,551$252,386
20234596,375$448,463
20244325,224$345,302

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$531K$1.1M2015 Drug cost: $198,935 (USD; Tot_Drug_Cst)2016 Drug cost: $211,119 (USD; Tot_Drug_Cst)2017 Drug cost: $248,065 (USD; Tot_Drug_Cst)2018 Drug cost: $204,605 (USD; Tot_Drug_Cst)2019 Drug cost: $350,804 (USD; Tot_Drug_Cst)2020 Drug cost: $467,094 (USD; Tot_Drug_Cst)2021 Drug cost: $677,027 (USD; Tot_Drug_Cst)2022 Drug cost: $460,148 (USD; Tot_Drug_Cst)2023 Drug cost: $501,777 (USD; Tot_Drug_Cst)2024 Drug cost: $1,062,487 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154101,300$198,935
20163811,327$211,119
20173911,266$248,065
20184271,374$204,605
20194251,317$350,804
20204151,427$467,094
20214101,298$677,027
20224071,481$460,148
20234101,595$501,777
20244211,616$1,062,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths122147$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more150247$61
17000Destruction of precancer skin growth, 1 growth269434$39
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more274507$39
17003Destruction of precancer skin growth, 2-14 growths2121,382$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa13868$265,491
Dupixent PenDupilumab601,652$234,047
OtezlaApremilast31930$163,086
Humira(Cf) PenAdalimumab15420$101,763
Clobetasol PropionateClobetasol Propionate2466,705$12,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.59$1,112ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael K. Weil, M.D.?

Tedicare shows public-source Medicare data for Michael K. Weil, M.D. (NPI 1780750802), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael K. Weil, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael K. Weil, M.D.?

Michael K. Weil, M.D. is linked to MICHAEL K WEIL, MD, APMC (billing NPI 1730255878) in the available physician profile data.

Does Michael K. Weil, M.D. have Open Payments data?

Michael K. Weil, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.